B-FLEXION Life Sciences to Acquire Remaining 57% of Radius Health from Patient Square and Webster Equity Partners
January 12, 2026
B-FLEXION Life Sciences has agreed to purchase the remaining 57% interest in Radius Health held by affiliates of Patient Square Capital and Webster Equity Partners. Radius, a specialty biopharmaceutical focused on bone health, had been taken private by B-FLEXION and Patient Square in August 2022. The transaction is expected to close by the end of Q1 2026.
- Buyers
- B-FLEXION Life Sciences
- Targets
- Radius Health
- Sellers
- Affiliates of Patient Square Capital, Webster Equity Partners
- Industry
- Pharmaceuticals
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Gurnet Point Capital and Patient Square Capital Acquire Radius Health
June 23, 2022
Healthcare Services
Gurnet Point Capital and Patient Square Capital entered into a definitive agreement to acquire Radius Health in a transaction valued at approximately $890 million, including the assumption of debt. The offer is $10.00 per share in cash plus a $1.00 per share contingent value right (CVR) tied to TYMLOS (abaloparatide) net sales reaching $300 million during a 12-month period prior to December 31, 2025.
-
Paratek Pharmaceuticals and Radius Health Combination Supported by $1.3B Financing Led by Blackstone Credit & Insurance
March 20, 2026
Pharmaceuticals
Blackstone Credit & Insurance is leading a $1.3 billion financing to support the combination of Paratek Pharmaceuticals and Radius Health, creating a scaled, multi-asset specialty pharmaceutical platform. The combined company is expected to integrate commercial-stage assets and lifecycle/clinical development efforts to expand a diversified portfolio of targeted medicines.
-
Pacira BioSciences Acquires Flexion Therapeutics
October 11, 2021
Pharmaceuticals
Pacira BioSciences agreed to acquire Flexion Therapeutics for $8.50 per share in cash plus one contingent value right (CVR) worth up to $8.00 per share tied to sales and regulatory milestones. The deal adds Flexion's marketed non-opioid OA knee pain therapy ZILRETTA and its clinical-stage pipeline to Pacira's non-opioid pain management portfolio; the transaction was expected to close in Q4 2021 and to be accretive to Pacira's earnings.
-
AgencyBloc Acquires Radius
February 1, 2023
Cloud & SaaS
AgencyBloc, a Resurgens-backed agency management system provider, has acquired Radius, a Las Vegas-based sales enablement provider for life and health insurance brokers. The add-on expands AgencyBloc's sales enablement capabilities — including lead distribution, texting and integrated VoIP/call routing — to accelerate its vision of a single, end-to-end platform for brokers and high-volume organizations.
-
Warburg Pincus and Tilia Acquire FlexXray from Levine Leichtman Capital Partners
July 26, 2021
Food & Beverage
Warburg Pincus and Tilia Holdings have acquired FlexXray, a leading provider of x-ray inspection and recovery services for the food industry, from Levine Leichtman Capital Partners. The investment is intended to support FlexXray's growth and expansion of its food-safety inspection capabilities and geographic reach; financial terms were not disclosed.
-
Banyan Software Acquires HealthRx Corporation
June 15, 2021
Software
Banyan Software, a permanent-capital enterprise software acquirer, has purchased HealthRx Corporation, a Fairfax, Virginia–based provider of research workflow, lab safety and occupational health management software (the Nexus platform). The acquisition brings HealthRx's specialized compliance and medical surveillance capabilities into Banyan's portfolio to support continued investment and product growth in the biomedical research and government health markets.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.